Instil Bio, Inc. (TIL)
Last updated: 2026-10-21 16:15:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Instil Bio, Inc. (TIL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $6.10, with a market capitalization of $39.27M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.62 to $20.32. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$39.27M | |
$6.01 | |
$589.80 | |
$5.62 | |
$5.94 | |
5.12K | |
17.58K | |
-- | |
$20.32 | |
$5.62 | |
-- | |
-- |
Instil Bio, Inc. (TIL) Stock Price Today
Instil Bio, Inc. (TIL) is currently trading at $6.10 as of 2026-10-21 16:13:00, up 2.61% ($0.15) from the previous close of $5.94
During today's regular trading session, TIL has traded between $5.62 and $589.80, with a trading volume of 5.12K shares. The current price is near the lower end of today's range.
Instil Bio, Inc. (TIL) 7-Day Stock Price Change
Over the past seven days, Instil Bio, Inc. (TIL) moved from $6.58 to $6.10, representing a decline of 7.37% ($0.49).
The stock traded between $5.62 and $6.66 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 55.62 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
TIL 52-Week Price Position
Position in Range: 3.2%
TIL is currently trading at $6.10, placing it 3.2% of the way from its 52-week low of $5.62 to its 52-week high of $20.32. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Instil Bio, Inc. (TIL)?
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Instil Bio, Inc. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 17 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Instil Bio, Inc. (TIL) Stock on MEXC
Eligible investors can buy real shares of Instil Bio, Inc. (TIL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Instil Bio, Inc. (TIL) stock price today?
2.Is TIL stock going up or down today?
3.What is TIL pre-market price?
4.What is TIL after-hours price?
5.Is TIL stock trading now?
6.Where does TIL sit relative to its 52-week high and low?
7.What sector is Instil Bio, Inc. in?
8.What is Instil Bio, Inc.'s market capitalization and where is it listed?
9.How is TIL valued in terms of P/E ratio and EPS?
10.Does Instil Bio, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
TIL Stock Calculator
Estimate the value between TIL shares and USD.
TIL Shares to USD
1.00 TIL shares = 6.095 USD
Calculations are estimates based on the latest available price and are for reference only.


